Gestalt Diagnostics and MindPeak today announced their strategic relationship on the development of an integrated workflow for pathologists to instantaneously send regions of interest to MindPeak. MindPeak’s Image Analysis services for digital images support ER, PR and Ki-67. The companies are providing a faster, more streamlined diagnostic process for breast cancer patients.
“By integrating with MindPeak we are providing Pathologists with the ability to select regions of
interest on a digital image, automatically send that to MindPeak and receive their annotated results
back in real-time.” says Gestalt COO & Chief Strategy Officer, Lisa-Jean Clifford. “Providing
Pathologist’s instant access to AI algorithms directly within their workflow not only increases their
efficiency, it helps speed the time to diagnosis and ultimately to treatment for cancer patients. This
can have a significant impact on the pathologist’s turn-around times, accuracy and greatly impact the
outcome for individual patients.”
“The Gestalt platform is an optimal environment to make our AI accessible to pathologists. The
combination of an excellent platform with sophisticated AI is what will bring pathology forward in the
future.” said Felix Faber, MindPeak’s CEO.
Visit Gestalt at the Pathology Visions conference Oct 6-9, 2019 in booths #302 and #314 to learn
more.
About Gestalt Diagnostics
Gestalt Diagnostics is a private, profit-driven software company who provides technology solutions,
technical and integration services and support to pathology laboratories. Gestalt has developed
PathFlow, an enterprise software platform specifically designed to bring the benefits of digital
workflow to pathologists and pathology laboratories. This product was originally developed, by what is
now Gestalt’s team, to support a fully digital reading platform for radiology. The radiology platform is
used in leading hospitals across the United States and supports more than 15 million studies
annually. Gestalt has expanded and redesigned this proven, robust solution to work in the laboratory
space – engineered for the unique needs and workflow of pathologists. To learn more, visit
www.gestaltdiagnostics.com.
About MindPeak
MindPeak is based in Hamburg, Germany and has the mission is to increase the accuracy of cancer
diagnostics and make it accessible to everyone who is in need. MindPeak’s software tools are based
on artificial intelligence and assist the pathologist in routine diagnostics. The software makes it easier
and more efficient to solve repetitive standard tasks, which are not challenging for the expert, but
tedious and error-prone. MindPeak has developed BreastAI, a software for fast and accurate
quantification of breast cancer IHC’s which can be integrated as a service in third party software.
MindPeak’s products are for research use only. Visit www.mindpeak.ai for more information
